Inference of causal and pleiotropic effects with multiple weak genetic instruments: application to effect of adiponectin on type 2 diabetes
View ORCID ProfilePaul M McKeigue, View ORCID ProfileAndrii Iakovliev, View ORCID ProfileAthina Spiliopoulou, View ORCID ProfileBuddhiprabha Erabadda, View ORCID ProfileHelen M Colhoun
doi: https://doi.org/10.1101/2023.12.15.23300008
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
2Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
Andrii Iakovliev
2Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
Athina Spiliopoulou
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
Buddhiprabha Erabadda
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
Helen M Colhoun
2Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland

Data Availability
UK Biobank data are available to approved researchers via managed access. A guide to accessing data is available at https://biobank.ctsu.ox.ac.uk/crystal/exinfo.cgi?src=accessing_data_guide
Posted April 09, 2024.
Inference of causal and pleiotropic effects with multiple weak genetic instruments: application to effect of adiponectin on type 2 diabetes
Paul M McKeigue, Andrii Iakovliev, Athina Spiliopoulou, Buddhiprabha Erabadda, Helen M Colhoun
medRxiv 2023.12.15.23300008; doi: https://doi.org/10.1101/2023.12.15.23300008
Inference of causal and pleiotropic effects with multiple weak genetic instruments: application to effect of adiponectin on type 2 diabetes
Paul M McKeigue, Andrii Iakovliev, Athina Spiliopoulou, Buddhiprabha Erabadda, Helen M Colhoun
medRxiv 2023.12.15.23300008; doi: https://doi.org/10.1101/2023.12.15.23300008
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)